Resources relating to TLD transition

ARC performed an independent advisory role to shape the overall TLD transition project and brokered additional expert resources from Novo Nordisk and a local private sector consultant to support the initiative.

ARC supported the NDoH to plan the introduction of TLD, while maintaining full availability of both the old and new regimens.

ARC developed a tool for the NDoH that gives insight into whether provinces had the right quantity of medicines to meet the Covid-19 medicines demand forecast.